202 related articles for article (PubMed ID: 28464736)
1. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation.
Ödén J; Eriksson K; Toma-Dasu I
Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
3. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
4. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.
Resch AF; Landry G; Kamp F; Cabal G; Belka C; Wilkens JJ; Parodi K; Dedes G
Phys Med; 2017 Apr; 36():91-102. PubMed ID: 28410691
[TBL] [Abstract][Full Text] [Related]
6. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
7. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
8. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
9. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
11. Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning, and RBE model predictions on RBE-weighted dose distributions.
Hofmaier J; Dedes G; Carlson DJ; Parodi K; Belka C; Kamp F
Med Phys; 2021 Feb; 48(2):805-818. PubMed ID: 33210739
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
13. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
Bai X; Lim G; Grosshans D; Mohan R; Cao W
Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
[TBL] [Abstract][Full Text] [Related]
14. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
15. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
16. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
17. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization.
Tommasino F; Widesott L; Fracchiolla F; Lorentini S; Righetto R; Algranati C; Scifoni E; Dionisi F; Scartoni D; Amelio D; Cianchetti M; Schwarz M; Amichetti M; Farace P
Phys Med Biol; 2020 Feb; 65(4):045002. PubMed ID: 31851957
[TBL] [Abstract][Full Text] [Related]
18. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
19. Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver.
Carabe A; España S; Grassberger C; Paganetti H
Phys Med Biol; 2013 Apr; 58(7):2103-17. PubMed ID: 23470339
[TBL] [Abstract][Full Text] [Related]
20. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
Wedenberg M; Toma-Dasu I
Med Phys; 2014 Sep; 41(9):091706. PubMed ID: 25186381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
